FDA Will Look “Very Closely” To Ensure PREA Compliance On OTC Labels
This article was originally published in The Tan Sheet
Executive SummaryFDA will scrutinize proposed product labels to ensure they include information on pediatric use in compliance with the Pediatric Research Equity Act, according to an agency executive
You may also be interested in...
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.